CD19-targeting fusion protein combined with PD1 antibody enhances anti-tumor immunity in mouse models.

In our earlier research, utilizing a B cell vaccine (scFv-Her2), the concentrating on of tumor-associated antigen Her2 (human epidermal progress issue receptor-2) to B cells by way of the anti-CD19 single chain variable fragment (scFv) was proven to enhance tumor-specific immunity, which enhanced tumor management in the prophylactic and therapeutic setting. However, the fusion protein displayed restricted exercise in opposition to established tumors, and native relapses usually occurred following scFv-Her2 remedy, indicating that scFv-Her2-induced responses are insufficient to take care of anti-tumor immunity.

 

In this research, concentrating on the IV area (D4) of the extracellular area of Her2 to B cells by way of CD19 molecules (scFv-Her2D4) was discovered to reinforce IFN-γ-producing-CD8+ T cell infiltration in tumor tissues and decreased the variety of tumor-infiltrating myeloid-derived suppressor cells (MDSCs). However, adverse co-stimulatory molecules comparable to programmed cell loss of life protein-1 (PD-1), CD160, and LAG-Three on T cells and programmed loss of life protein ligand-1 (PD-L1) on tumor cells have been upregulated in the tumor microenvironment after scFv-Her2D4 remedy. Further, anti-PD1 administration enhanced the efficacy of scFv-Her2D4 and anti-tumor immunity, as evidenced by the reversal of tumor-infiltrating CD8+ T cell exhaustion and the discount of MDSCs and Treg cells, which suppress T cells and alter the tumor immune microenvironment.

 

Moreover, combining this with anti-PD1 antibodies promoted full tumor rejection. Our knowledge present proof of an in depth interplay amongst tumor vaccines, T cells, and the PD-L1/PD-1 axis and set up a foundation for the rational design of mixture remedy with immune modulators and tumor vaccine remedy.

 CD19-targeting fusion protein combined with PD1 antibody enhances anti-tumor immunity in mouse models.

CD19-targeting fusion protein combined with PD1 antibody enhances anti-tumor immunity in mouse models.

Anti-inflammatory, analgesic exercise, and toxicity of Pituranthos scoparius stem extract: An ethnopharmacological research in rat and mouse fashions.

<AbstractText>Pituranthos scoparius is a medicinal plant that’s used in conventional drugs in Algeria and different North African nations to deal with a number of illnesses comparable to bronchial asthma, rheumatism, measles, dermatoses, jaundice, and digestive problems.</AbstractText><AbstractText>The current investigation was designed to research an ethnobotanical survey about Pituranthos scoparius in Setif area, Algeria, and assess the acute toxicity, in vivo anti-inflammatory potential and analgesic impact of Pituranthos scoparius stem h widespread drugs.</AbstractText><p><div><b>MATERIALS AND METHODS</b></div>Acute toxicity of PSSE was carried out primarily based on OECD pointers 425.
Both potential loss of life and indicators accompanying toxicity of animals have been monitored for 14 days to determine the median deadly dose (LD<sub>50</sub>) of PSSE. Anti-inflammatory impact of the extract was evaluated utilizing the xylene, croton oil-induced ear edema, and carrageenan-induced paw edema, whereas the analgesic exercise was evaluated utilizing acetic acid-induced stomach constriction in mice mannequin.</p><p><div><b>RESULTS</b></div>Data from the ethnopharmacological survey confirmed that 24.47% of individuals used this plant in conventional (people) drugs Results additionally revealed that PSSE comprises excessive quantities of polyphenols, flavonoids, and tannins, and that the extract didn’t trigger any deaths or adjustments in the conduct of handled animals; LD<sub>50</sub> values have been discovered to be greater than 5 g/kg DW.

Biolipidure-103-Reagent

Biolipidure-103-100 100mL
EUR 1223.00
  • Biolipidure enhances sensitivity and accuracy.
  • Biolipidure suppresses non-specific adsorption.
  • Biolipidure stabilizes antibodies and enzymes.
  • Biolipidure eliminates lot-to-lot variations.
  • Biolipidure does not require biohazardous handling.
Description: The Biolipidure-103-Reagent is a synthetic amphoteric polymer that can be substituted for BSA. It has been shown to enhance signals in rapid tests, western blots, and other similar immunochromatographic assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement

Mouse pre-microRNA Expression Construct mir-103-1

MMIR-103-1-PA-1 Bacterial Streak
EUR 684.00
  • Category: MicroRNA Tools

Mouse pre-microRNA Expression Construct mir-103-2

MMIR-103-2-PA-1 Bacterial Streak
EUR 684.00
  • Category: MicroRNA Tools

ICP 103

A8801-5 5 mg
EUR 142.00
Description: ICP 103

ICP 103

A8801-5.1 10 mM (in 1mL DMSO)
EUR 166.00
Description: ICP 103

PI-103

1728-1
EUR 153.00

PI-103

1728-5
EUR 419.00

PI-103

1728-50 Ask for price

TAS-103

B1841-25
EUR 588.00

TAS-103

B1841-5
EUR 185.00

PI-103

HY-10115 100mg
EUR 546.00

CB-103

HY-135145 100mg
EUR 131.00

TAS-103

HY-13758 100mg
EUR 1359.00

AM 103

HY-14163 1mg
EUR 2254.00

PI-103

A2067-100 100 mg
EUR 838.00
Description: PI-103 is a potent and selective inhibitor of class I PI3K, mTOR and DNA-PK with IC50 values of 2, 3, 3, 15, 30 and 23 nM for p110?, p110?, p110?, p110?, mTOR and DNA-PK, respectively [1].

PI-103

A2067-25 25 mg
EUR 328.00
Description: PI-103 is a potent and selective inhibitor of class I PI3K, mTOR and DNA-PK with IC50 values of 2, 3, 3, 15, 30 and 23 nM for p110?, p110?, p110?, p110?, mTOR and DNA-PK, respectively [1].

PI-103

A2067-5 5 mg
EUR 147.00
Description: PI-103 is a potent and selective inhibitor of class I PI3K, mTOR and DNA-PK with IC50 values of 2, 3, 3, 15, 30 and 23 nM for p110?, p110?, p110?, p110?, mTOR and DNA-PK, respectively [1].

PI-103

A2067-5.1 10 mM (in 1mL DMSO)
EUR 154.00
Description: PI-103 is a potent and selective inhibitor of class I PI3K, mTOR and DNA-PK with IC50 values of 2, 3, 3, 15, 30 and 23 nM for p110?, p110?, p110?, p110?, mTOR and DNA-PK, respectively [1].

PI-103

A2067-S Evaluation Sample
EUR 81.00
Description: PI-103 is a potent and selective inhibitor of class I PI3K, mTOR and DNA-PK with IC50 values of 2, 3, 3, 15, 30 and 23 nM for p110?, p110?, p110?, p110?, mTOR and DNA-PK, respectively [1].

PI-103

E1KS1038 5mg
EUR 325.00

LB (Miller)

103 500 g
EUR 100.00

miRZip-103 anti-miR-103 microRNA construct

MZIP103-PA-1 Bacterial Streak
EUR 684.00
  • Category: MicroRNA Tools

PI-103 (Hydrochloride)

HY-10115A 5mg
EUR 119.00

TAS-103 (dihydrochloride)

HY-13758A 10mM/1mL
EUR 231.00

PI-103 Hydrochloride

A3724-100 100 mg
EUR 838.00
Description: PI-103 is a dual inhibitor of PI3K/Akt and mTOR with IC50 value of 0.002 ?M , 0.003?M, 0.003?M, 0.015?M, 0.030?M for P110?, P110?, P110?, P110 and mTOR, respectively.

PI-103 Hydrochloride

A3724-25 25 mg
EUR 328.00
Description: PI-103 is a dual inhibitor of PI3K/Akt and mTOR with IC50 value of 0.002 ?M , 0.003?M, 0.003?M, 0.015?M, 0.030?M for P110?, P110?, P110?, P110 and mTOR, respectively.

PI-103 Hydrochloride

A3724-5 5 mg
EUR 147.00
Description: PI-103 is a dual inhibitor of PI3K/Akt and mTOR with IC50 value of 0.002 ?M , 0.003?M, 0.003?M, 0.015?M, 0.030?M for P110?, P110?, P110?, P110 and mTOR, respectively.

PI-103 Hydrochloride

A3724-5.1 10 mM (in 1mL DMSO)
EUR 154.00
Description: PI-103 is a dual inhibitor of PI3K/Akt and mTOR with IC50 value of 0.002 ?M , 0.003?M, 0.003?M, 0.015?M, 0.030?M for P110?, P110?, P110?, P110 and mTOR, respectively.

Apo B48 / 103 Antibody

abx023235-1mg 1 mg
EUR 551.00
  • Shipped within 5-10 working days.

[Ala92]-p16 (84-103)

B5220-1 1 mg
EUR 312.00

GJ-103 Sodium salt

B1842-25
EUR 588.00

GJ-103 Sodium salt

B1842-5
EUR 185.00

HOM-TES-103 antibody

70R-9325 50 ug
EUR 467.00
Description: Affinity purified rabbit polyclonal HOM-TES-103 antibody

BAD (103 - 126), human

5-00743 4 x 1mg Ask for price

BAD (103 - 127), human

5-00744 4 x 1mg Ask for price

HOM-TES-103 antibody

70R-2059 50 ug
EUR 467.00
Description: Rabbit polyclonal HOM-TES-103 antibody raised against the N terminal Of Hom-Tes-103

[Ala92]-p16 (84-103)

E1KP1077 1mgPHYSICAL AND CHEMICAL PROPERTIES
EUR 456.00

rno-miR-103 Primers

MP-r00085 150 ul / 10 uM
EUR 176.00

hsa-miR-103 Primers

MPH01017 150 ul / 10 uM
EUR 121.00

mmu-miR-103 Primers

MPM00019 150 ul / 10 uM
EUR 121.00

HOM-TES-103 Blocking Peptide

33R-6035 100 ug
EUR 180.00
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of HOM-TES-103 antibody, catalog no. 70R-2059

HOM-TES-103 Blocking Peptide

33R-9752 100 ug
EUR 180.00
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of HOM-TES-103 antibody, catalog no. 70R-9325

Yeast TRX1 (aa 1 - 103)

DAG1755 500 ug
EUR 915.00

hsa-miR-103-as Primers

MPH01018 150 ul / 10 uM
EUR 121.00

mmu-miR-103-3p Primers

MPM00763 150 ul / 10 uM
EUR 121.00

rno-miR-103-3p Primers

MPR00332 150 ul / 10 uM
EUR 176.00

rno??miR-103 miRNA Inhibitor

MIR01036 2 x 5.0 nmol
EUR 176.00

hsa-miR-103 miRNA Antagomir

MNH01033 2 x 5.0 nmol
EUR 329.00

hsa-miR-103 miRNA Inhibitor

MIH01033 2 x 5.0 nmol
EUR 176.00

mmu-miR-103 miRNA Inhibitor

MIM01040 2 x 5.0 nmol
EUR 176.00

rno??miR-103 miRNA Antagomir

MNR01036 2 x 5.0 nmol
EUR 329.00

mmu-miR-103 miRNA Antagomir

MNM01040 2 x 5.0 nmol
EUR 329.00

Anti-HDGFRP3 (aa89-103) antibody

STJ73156 100 µg
EUR 359.00

Anti-UBID4 (aa89-103) antibody

STJ73541 100 µg
EUR 359.00

Cellufine MAX Butyl

21-103 10 lt Ask for price

Mouse IgG2b isotype control, purified

20102-103 100 ug
EUR 141.00

PhosphoBlocker Blocking Reagent

AKR-103 1L
EUR 328.00
Description: Most commercially available Western blot blockers, such as dry milk or serum, are sufficient to block unreactive sites on the membrane. However, they are not designed to preserve phosphoprotein antigens during blotting. Our PhosphoBLOCKER Blocking Reagent provides superior blocking by maximizing signal-to-noise ratio. The PhosphoBLOCKER reagent particluarly excels with very low levels of endogenous phopsphoproteins.

CytoSelect 24-well Cell Migration Assay (3 ?m), Fluorometric

CBA-103 12 assays
EUR 554.00
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 3 µm pore size is best for the smallest cells including neutrophils and other leukocytes.

Surfactant 10G

95R-103 100 gram
EUR 273.00
Description: Surfactant 10G for use as a detergent, wetting agent, emulsifier, foaming agent, and dispersant.

Microcide III

99R-103 500 ml
EUR 354.00
Description: Microcide compound for broad-spectrum antimicrobial activity against bacteria and fungi and are compatible with most formulations.

Immunoassay Stabilizer

85R-103 1 liter
EUR 481.00
Description: Stabilizing buffer for use in immunoassays

Recombinant Rat Complement Regulatory Protein

CTP-103 100ug Ask for price
Description: A 54.8 kDa recombinant rat Complement Regulatory protein with a 6His tag at N-terminus tag expressed in E. Coli or Yeast or Baculovirus or Mammalian Cell.

Recombinant Newcastle Disease Virus Nucleoprotein (aa1-489) [His]

DAGF-103 10ug
EUR 645.00

Platinum-GP Retroviral Packaging Cell Line, Pantropic

RV-103 1 vial
EUR 920.00
Description: Conventional cells used for retrovirus packaging, such as those based on NIH3T3 cells, have limited stability and produce relatively low yields of retrovirus, mainly due to the poor expression of retroviral structure proteins (gag, pol and env) in the cells. The Platinum Retroviral Packaging Cell Lines are based on the 293T cell line. They exhibit longer stability and produce higher yields of retroviral structure proteins. Plat-GP cells contain the gag and pol genes required for retroviral packaging; an expression vector is co-transfected with a VSVG envelope vector.

Prepro-Neuromedin S (70-103) (human)

H-6296.0500 0.5mg
EUR 515.00
Description: Sum Formula: C180H271N49O44S; CAS# [894454-10-5] net

Prepro-Neuromedin S (70-103) (human)

H-6296.1000 1.0mg
EUR 877.00
Description: Sum Formula: C180H271N49O44S; CAS# [894454-10-5] net

Prepro-Neuromedin S (70-103) (human)

5-01802 4 x 1mg Ask for price

mmu-miR-103-1-5p Primers

MPM00761 150 ul / 10 uM
EUR 121.00

mmu-miR-103-2-5p Primers

MPM00762 150 ul / 10 uM
EUR 121.00

rno-miR-103-1-5p Primers

MPR00330 150 ul / 10 uM
EUR 176.00

rno-miR-103-2-5p Primers

MPR00331 150 ul / 10 uM
EUR 176.00

rno-miR-103-3p miRNA Inhibitor

MIR01039 2 x 5.0 nmol
EUR 176.00

hsa-miR-103-as miRNA Antagomir

MNH01036 2 x 5.0 nmol
EUR 329.00

hsa-miR-103-as miRNA Inhibitor

MIH01036 2 x 5.0 nmol
EUR 176.00

mmu-miR-103-3p miRNA Inhibitor

MIM01043 2 x 5.0 nmol
EUR 176.00

rno-miR-103-3p miRNA Antagomir

MNR01039 2 x 5.0 nmol
EUR 329.00

mmu-miR-103-3p miRNA Antagomir

MNM01043 2 x 5.0 nmol
EUR 329.00

G-Protein Coupled Receptor 103 (GPR103) Antibody

20-abx015472
  • EUR 314.00
  • EUR 98.00
  • EUR 398.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg
  • Shipped within 5-10 working days.

Coiled-Coil Domain Containing 103 (CCDC103) Antibody

abx146281-100ug 100 ug
EUR 391.00
  • Shipped within 5-10 working days.

hsa-mir-103 RT-PCR Detection Kit

20-abx096087
  • EUR 537.00
  • EUR 732.00
  • EUR 398.00
  • 100 rxns
  • 200 rxns
  • 50 rxns
  • Shipped within 5-10 working days.

hsa-mir-103 RT-PCR Primer Set

abx096841-1nmol 1 nmol
EUR 286.00
  • Shipped within 5-10 working days.

Coiled-Coil Domain Containing 103 (CCDC103) Antibody

20-abx318615
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

G-Protein Coupled Receptor 103 (GPR103) Antibody

20-abx119627
  • EUR 314.00
  • EUR 98.00
  • EUR 398.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg
  • Shipped within 5-10 working days.

Chromosome 9 Open Reading Frame 103 Protein

20-abx262491
  • EUR 328.00
  • EUR 6397.00
  • EUR 230.00
  • 10 ug
  • 1 mg
  • 2 µg
  • Shipped within 5-10 working days.

Human Beta-Defensin 103 (DEFB103A) ELISA Kit

abx253774-96tests 96 tests
EUR 668.00
  • Shipped within 5-12 working days.

Zinc Finger Protein 103 Homolog (ZFP103) Antibody

abx430031-200ul 200 ul
EUR 286.00
  • Shipped within 1-3 working days.

Human DEFB103A(Beta-defensin 103) ELISA Kit

EH0817 96T
EUR 567.60
  • Detection range: 0.156-10 ng/ml
  • Uniprot ID: P81534
  • Alias: DEFB103A(Beta-defensin 103)/DEFB3/BD14/BD3/DEFB103B/HBD-3/BD-3/Beta-defensin 3/DEFB103/DEFB-3/DEFB3DEFB103A/Defensin, beta 103/defensin, beta 103B/Defensin-like protein/hBD-3/HBD3HBP3
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.094 ng/ml

Human DEFB103A/ Beta-defensin 103 ELISA Kit

E0676Hu 1 Kit
EUR 571.00

Histone H4 (1-103 aa), Human recombinant

7671-100
EUR 229.00

Histone H4 (1-103 aa), Human recombinant

7671-250
EUR 446.00

Protein Kinase p34(cd2) Substrate; CSH 103

5-01843 4 x 1mg Ask for price

rno-miR-103-1-5p miRNA Inhibitor

MIR01037 2 x 5.0 nmol
EUR 176.00

rno-miR-103-2-5p miRNA Inhibitor

MIR01038 2 x 5.0 nmol
EUR 176.00

mmu-miR-103-1-5p miRNA Inhibitor

MIM01041 2 x 5.0 nmol
EUR 176.00

mmu-miR-103-2-5p miRNA Inhibitor

MIM01042 2 x 5.0 nmol
EUR 176.00

rno-miR-103-1-5p miRNA Antagomir

MNR01037 2 x 5.0 nmol
EUR 329.00

rno-miR-103-2-5p miRNA Antagomir

MNR01038 2 x 5.0 nmol
EUR 329.00

mmu-miR-103-1-5p miRNA Antagomir

MNM01041 2 x 5.0 nmol
EUR 329.00

mmu-miR-103-2-5p miRNA Antagomir

MNM01042 2 x 5.0 nmol
EUR 329.00

Prepro-Neuromedin S (NMS, 70-103) (human)

SP-100036-1 1 mg
EUR 286.00

Coiled-Coil Domain Containing 103 (CCDC103) Antibody (HRP)

20-abx308578
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Coiled-Coil Domain Containing 103 (CCDC103) Antibody (FITC)

20-abx308579
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Coiled-Coil Domain Containing 103 (CCDC103) Antibody (Biotin)

20-abx308580
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Monoclonal Caspase-3 Antibody (Pro), Clone: E83-103

APG02401G 0.1ml
EUR 528.00
Description: A Monoclonal antibody against Human Caspase-3 (Pro). The antibodies are raised in Rabbit and are from clone E83-103. This antibody is applicable in WB and IHC

Anti-BDH2 / DHRS6 (aa 92 to 103) antibody

STJ71470 100 µg
EUR 260.00

Recombinant Shigella Dysenteriae rplU Protein (aa 1-103)

VAng-Lsx07141-1mgEcoli 1 mg (E. coli)
EUR 2869.00
Description: Shigella Dysenteriae serotype 1 (strain Sd197) 50S ribosomal protein L21, recombinant protein.

Recombinant Shigella Dysenteriae rplU Protein (aa 1-103)

VAng-Lsx07141-500gEcoli 500 µg (E. coli)
EUR 2044.00
Description: Shigella Dysenteriae serotype 1 (strain Sd197) 50S ribosomal protein L21, recombinant protein.

Recombinant Shigella Dysenteriae rplU Protein (aa 1-103)

VAng-Lsx07141-50gEcoli 50 µg (E. coli)
EUR 1411.00
Description: Shigella Dysenteriae serotype 1 (strain Sd197) 50S ribosomal protein L21, recombinant protein.

Recombinant Shigella Dysenteriae rpsJ Protein (aa 1-103)

VAng-Lsx07167-1mgEcoli 1 mg (E. coli)
EUR 2869.00
Description: Shigella Dysenteriae serotype 1 (strain Sd197) 30S ribosomal protein S10, recombinant protein.

Recombinant Shigella Dysenteriae rpsJ Protein (aa 1-103)

VAng-Lsx07167-500gEcoli 500 µg (E. coli)
EUR 2044.00
Description: Shigella Dysenteriae serotype 1 (strain Sd197) 30S ribosomal protein S10, recombinant protein.

Recombinant Shigella Dysenteriae rpsJ Protein (aa 1-103)

VAng-Lsx07167-50gEcoli 50 µg (E. coli)
EUR 1411.00
Description: Shigella Dysenteriae serotype 1 (strain Sd197) 30S ribosomal protein S10, recombinant protein.

Recombinant Shigella Dysenteriae yqfB Protein (aa 1-103)

VAng-Lsx07345-1mgEcoli 1 mg (E. coli)
EUR 2869.00
Description: Shigella Dysenteriae serotype 1 (strain Sd197) UPF0267 protein yqfB, recombinant protein.

Recombinant Shigella Dysenteriae yqfB Protein (aa 1-103)

VAng-Lsx07345-500gEcoli 500 µg (E. coli)
EUR 2044.00
Description: Shigella Dysenteriae serotype 1 (strain Sd197) UPF0267 protein yqfB, recombinant protein.

Recombinant Shigella Dysenteriae yqfB Protein (aa 1-103)

VAng-Lsx07345-50gEcoli 50 µg (E. coli)
EUR 1411.00
Description: Shigella Dysenteriae serotype 1 (strain Sd197) UPF0267 protein yqfB, recombinant protein.

Recombinant Shigella Dysenteriae ftsB Protein (aa 1-103)

VAng-Lsx07409-1mgEcoli 1 mg (E. coli)
EUR 3349.00
Description: Shigella Dysenteriae serotype 1 (strain Sd197) Cell division protein FtsB, recombinant protein.

Recombinant Shigella Dysenteriae ftsB Protein (aa 1-103)

VAng-Lsx07409-500gEcoli 500 µg (E. coli)
EUR 2346.00
Description: Shigella Dysenteriae serotype 1 (strain Sd197) Cell division protein FtsB, recombinant protein.

Recombinant Shigella Flexneri rplU Protein (aa 1-103)

VAng-Lsx08103-1mgEcoli 1 mg (E. coli)
EUR 2869.00
Description: Shigella Flexneri 50S ribosomal protein L21, recombinant protein.

Recombinant Shigella Flexneri rplU Protein (aa 1-103)

VAng-Lsx08103-500gEcoli 500 µg (E. coli)
EUR 2044.00
Description: Shigella Flexneri 50S ribosomal protein L21, recombinant protein.

Recombinant Shigella Flexneri rplU Protein (aa 1-103)

VAng-Lsx08103-50gEcoli 50 µg (E. coli)
EUR 1411.00
Description: Shigella Flexneri 50S ribosomal protein L21, recombinant protein.

Recombinant Shigella Flexneri rpsJ Protein (aa 1-103)

VAng-Lsx08128-1mgEcoli 1 mg (E. coli)
EUR 2869.00
Description: Shigella Flexneri 30S ribosomal protein S10, recombinant protein.
Additionally, no important variations have been noticed in the alkaline phosphatase (ALP), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) enzymes, or in the degrees of urea and creatinine. Oral administration of PSSE on the doses of 100, 300, and 600 mg/kg produced a big dose-dependent inhibition impact in each xylene and croton oil-induced ear edema in mice. Administration of PSSE at a dose of 100, 250, and 500 mg/kg considerably (P ˂ 0.05) exhibited anti-edematogenic impact in the carrageenan-induced rat paw edema after Three h.